NxStage posts record-breaking Q3 results, shares gain 13%

Thu, 11/08/2012 - 3:25pm
Mass Device

NxStage boasts another solid quarter with a nearly double-digit increase in sales and halved 3rd quarter losses, gaining a 13% boost on Wall Street.

NxStage Medical logo

NxStage Medical (NSDQ:NXTM) posted yet another record-breaking quarter, cutting losses in half and reporting strong growth in sales.

The Lawrence, Mass.-based medical device maker posted $2.6 million in net losses, or 4¢ per share, on sales of $61.2 million for the 3 months ended Sept. 30. That compared with a net loss of $5.3 million, or 10¢ per share, on sales of $55.9 million during the same period last year.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.